Bayer, a German manufacturer of pharmaceuticals and agrochemicals, said that a jury in California, USA, concluded that its herb Roundup did not cause cancer in a woman. The company has secured a second trial victory for its defensive glyphosate, after a jury in Los Angeles (US) first ruled in Bayer’s favor in October. Earlier, Bayer had lost three cases related to Roundup.
Bare Roundup (Photo: Mike Blake/Reuters)
The San Bernardino court ruled in favor of the company when the victim said she had contracted non-Hodgkin’s lymphoma after using Roundup herbicide for more than 30 years. “The jury’s decision brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer,” a Bayer spokesperson said.
Bayer claims that Roundup, which it bought from US agrochemical company Monsanto for $63 billion, does not cause cancer. Germany-based company Leverkusen hopes a US Supreme Court ruling in a separate case will help end the herb’s years-long litigation. The legal issues surrounding Roundup prompted the company to set aside billions in provisions to resolve the cases.
Read more about companies and businesses
